Riskpilot← Back to searchSign inGet full accessCALYSTA AS
ASActiveOrg 991139796Professor Olav Hanssens Vei 15, 4021 StavangerResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20070 employees
Revenue 2023
NOK 0
EBITDA margin
—
+34% vs 2022
Equity ratio
-3346.0%
Financial strength
Net profit 2023
NOK -312K
+34% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -311K | +34% |
| Net profit | NOK -312K | +34% |
| Total assets | NOK 174K | +352% |
| Equity | NOK -5,8M | -6% |
| Employees | 0 | — |
Legal name
CALYSTA AS
Org number
991139796
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27. april 2007
Share capital
NOK 1 539 890
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Selskapet skal utvikle og kommersialisere gassbasert fermenteringsteknologi for produksjon og bioproteinderivater og av høyverdiprodukter basert på rekombinant teknologi.
Address
Professor Olav Hanssens Vei 15, 4021 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −605 | −530 | −693 | −472 | −311 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −605 | −530 | −693 | −472 | −311 |
| Net financials | −2 | 1 | −2 | −1 | −1 |
| Profit before tax | −607 | −529 | −696 | −472 | −312 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −607 | −529 | −696 | −472 | −312 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 94 | 69 | 35 | 38 | 174 |
| Equity | −3 815 | −4 343 | −5 039 | −5 511 | −5 824 |
| Long-term debt | 3 842 | 4 392 | 5 072 | 5 547 | 5 997 |
| Short-term debt | 67 | 20 | 2 | 3 | 1 |
| Total debt | 3 908 | 4 412 | 5 074 | 5 550 | 5 998 |
EBITDA margin
-31123500.0%
This company
15.8%
Market median
-196984277% vs market
20192023
Equity ratio
-3346.0%
This company
38.2%
Market median
-8859% vs market
20192023
Return on equity
-31232600.0%
This company
18.4%
Market median
-169742491% vs market
20192023
Net profit margin
-31232600.0%
This company
8.1%
Market median
-385587754% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AJ Contact Person | Contact Person | 2017 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Calysta Inc | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CALYSTA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arild Johannessen | Contact Person | 0 companies |
| Graham Ian Aylen | Board of Directors | 0 companies |
| George Blake Campbell | Chairman | 0 companies |